跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERA-2
首页
药物
SERA-2
SERA-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compositions and methods for immunodominant antigens
US 9297803 B2
申请人: FELGNER PHILIP
优先权: 2006
EP
US
WO
8 件公开
Synthetic chimeric fimbrin peptides
US 7229622 B2
申请人: UNIV OHIO STATE RES FOUND
优先权: 2002
US
4 件公开
Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
US 8029790 B2
申请人: BRAHMS GMBH
优先权: 2004
US
4 件公开
A BACTERIOPHAGE-BASED, NEEDLE AND ADJUVANT-FREE, MUCOSAL COVID-19 VACCINE
EP 4514386 A4
申请人: UNIV AMERICA CATHOLIC
优先权: 2022
EP
US
WO
3 件公开
SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF INTRACRANIAL HEMORRHAGIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF INTRACRANIAL HEMORRHAGIC STROKE FROM ACUTE ISCHEMIC STROKE
US 20260210978 A1
申请人: UNIV GDANSKI
优先权: 2022
EP
US
WO
3 件公开
Method of diagnosing esophageal cancer
EP 2298933 A1
申请人: ONCOTHERAPY SCIENCE INC
优先权: 2006
EP
US
3 件公开
Methods and Compositions Of Protein Antigens For The Diagnosis And Treatment of Herpes Simplex Viruses Type 1 and 2
US 2015037367 A1
申请人: DAVIES DAVID HUW
优先权: 2012
CN
US
2 件公开
USE OF A MIRNA INHIBITOR FOR THE TREATMENT OF OSTEOGENESIS IMPERFECTA
EP 4780958 A1
申请人: INST NAT SANTE RECH MED
优先权: 2023
EP
WO
2 件公开
Nuclear envelope protein recognized by atypical p-ANCA in patients with inflammatory bowel disease and autoimmune liver diseases
US 6627458 B2
申请人: UNIV COLUMBIA
优先权: 2001
US
2 件公开
Diagnostic for scleroderma
US 7262062 B2
申请人: UNIV KEIO
优先权: 2001
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈